Christa Firbas

Immunogenicity, safety, and tolerability of a recombinant measles-virus-based chikungunya vaccine: a randomised, double-blind, placebo-controlled, active-comparator, first-in-man trial

Katrin Ramsauer, Michael Schwameis, Christa Firbas et al. · The Lancet Infectious Diseases · 2015 · 227 citations

Vaccination, Vaccine Safety, Vaccinology +6

Safety and immunogenicity of a Vero-cell-derived, inactivated Japanese encephalitis vaccine: a non-inferiority, phase III, randomised controlled trial

Erich Tauber, Herwig Kollaritsch, Maria Korinek et al. · The Lancet · 2007 · 192 citations

Vaccinology, Vaccine Safety, Vaccination +6

Immunogenicity, safety, and tolerability of the measles-vectored chikungunya virus vaccine MV-CHIK: a double-blind, randomised, placebo-controlled and active-controlled phase 2 trial

Emil C. Reisinger, Roland Tschismarov, Eckhard Beubler et al. · The Lancet · 2018 · 176 citations

Vaccination, Vaccine Safety, Vaccinology +6

Validation of rotation thrombelastography in a model of systemic activation of fibrinolysis and coagulation in humans

Alexander Spiel, Florian Mayr, Christa Firbas et al. · Journal of Thrombosis and Haemostasis · 2006 · 166 citations · Full text

Rotation Thrombelastography, Thrombosis, Thrombopoiesis +12

A Randomized Clinical Trial of Anti–IL-6 Antibody Clazakizumab in Late Antibody-Mediated Kidney Transplant Rejection

Konstantin Doberer, Michael Duerr, Philip F. Halloran et al. · Journal of the American Society of Nephrology · 2020 · 162 citations · Full text